Search
Search Results
-
Newer Angiotensin Receptor Blockers
Angiotensin receptor blockers (ARBs) are among the most widely used classes of antihypertensive drugs. In addition to their established efficacy and...
-
Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy
Given possible involvement of the central and peripheral angiotensin system in pain processing, we conducted clinical and preclinical studies to test...
-
Retrospective analysis of neoplasms in patients using angiotensin receptor blockers
In recent years, regulatory agencies have raised concerns about the presence of potentially carcinogenic substances in certain formulations of...
-
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
Spondyloarthritis (SpA) is a chronic inflammatory disease that results in bone ankylosis. The tissue renin-angiotensin system (RAS) is an emerging...
-
ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock
BackgroundAngiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blockers (ARB) medications are widely prescribed. We sought to...
-
The role of angiotensin receptor blockers in treating epilepsy: a review
Epilepsy is a chronic brain disease with a global prevalence of 70 million people. According to the World Health Organization, roughly 5 million new...
-
Angiotensin Receptor Blockers and Cognition: a Sco** Review
Purpose of ReviewTo provide an overview of the association between angiotensin II receptor blocker (ARB) use and cognitive outcomes.
Recent Findings ...
-
Impact of calcium channel blockers and angiotensin receptor blockers on hematological parameters in type 2 diabetic patients
Antihypertensive medications have been associated with a reduction in hemoglobin (Hb) levels, leading to clinically significant anemia. We aimed to...
-
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea
IntroductionAngiotensin receptor blockers are widely used antihypertensive drugs in South Korea. In 2021, the Korea Ministry of Food and Drug Safety...
-
Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation
BackgroundHepatic steatosis is an increasing complication in liver transplant recipients. Currently, there is no pharmacologic therapy for treatment...
-
Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension
Diabetes mellitus is a common metabolic disorder characterized by chronic hyperglycemia and disturbance of carbohydrate, fats, and protein...
-
The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines
Arterial hypertension is the main preventable cause of premature mortality worldwide. Across Latin America, hypertension has an estimated prevalence...
-
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital
It has not yet been established whether angiotensin II receptor blockers (ARB), statins, and multiple drugs affect the severity of COVID-19....
-
Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: a network meta-analysis
BackgroundThe antihypertensive effects of angiotensin II receptor blockers (ARBs) are well recognized. However, conventional meta-analyses have...
-
Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis
Although angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) play critical roles in the treatment of heart...
-
Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study
BackgroundAngiotensin II receptor blockers (ARBs) reportedly reduce the risk of develo** bone fractures; however, this association remains unclear...
-
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
BackgroundRenin–angiotensin–aldosterone system (RAAS) is hypothesized to be in the center of COVID pathophysiology as the angiotensin converting...
-
Prophylactic effect of angiotensin receptor blockers in children with genetic aortopathies: the early bird catches the worm
AimsIn genetic aortopathies (GA) particular attention is paid to aortic root dilatation which has an impact on morbidity and mortality. This study...
-
Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study data
There is insufficient evidence that angiotensin-converting enzyme inhibitors (ACEIs) can reduce pneumonia by inducing a dry cough that confers a...
-
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Medications used to treat hypertension may affect fracture risk. This study investigated fracture risk for users of angiotensin converting enzyme...
